Marianne De Backer, MSc, Ph.D., MBA
Board Member
Vir Biotechnology, Inc. (VIR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Marianne De Backer, MSc, Ph.D., MBA
Marianne De Backer, MSc, Ph.D., MBA is recorded as CEO and Board Member at Vir Biotechnology, Inc. (VIR). Vir Biotechnology, Inc. reported in an 8-K filed January 25, 2023 that Marianne De Backer, MSc, Ph.D., MBA was appointed Class II director, effective April 3, 2023. Vir Biotechnology, Inc. reported in an 8-K filed January 25, 2023 that Marianne De Backer, MSc, Ph.D., MBA was appointed Chief Executive Officer, effective April 3, 2023.
“Dr. De Backer will be appointed to fill the newly created vacancy to serve on the Board as a Class II director until the Company's 2024 annual meeting of stockholders, and until her successor is duly elected and qualified, or until her earlier death, resignation or removal.”
“On January 19, 2023, the Board appointed Marianne De Backer, MSc, Ph.D., MBA, as Chief Executive Officer of the Company, effective as of April 3, 2023 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-04-03–present
-
Current
2023-04-03–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Vir Biotechnology, Inc.
Other people whose current roles at this company are on record from its filings.
- Aziz Sawaf CFO
- Brent Sabatini CFO
- Howard Horn CFO
- Jason O'Byrne CFO
- Johanna Friedl-Naderer COO
- Michael Kamarck CTO
- Vanina de Verneuil General Counsel
- Elliott Sigal Board Member
- Janet Napolitano Board Member
- Robert More Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.